The 500-Dalton Rule: Molecular Size and the Stratum Corneum

Apr 18

Molecular Size and the Stratum Corneum

Walk any skincare aisle and you will find products built around peptides, vitamin C derivatives, retinoids, sodium hyaluronate, niacinamide and dozens of other named ingredients. The quiet assumption behind most purchases is that, once applied, the ingredient stays where it can do its cosmetic job: in and on the stratum corneum.

Whether it gets there, and how much of it stays, depends less on the ingredient list than on two physical variables: the size of the molecule and the size of the vehicle carrying it.

The Stratum Corneum Is a Barrier by Design

The outermost layer of the skin, the stratum corneum, is a sheet roughly 10 to 20 micrometres thick. It is made of flattened corneocytes set in ordered lipid lamellae, principally ceramides, cholesterol and free fatty acids in an approximate 1:1:1 molar ratio. This structure keeps water in and the environment out, and it does that job continuously.

The same structure that protects the skin also limits how far a cosmetic ingredient travels from the surface. Every leave-on formula is, in practice, negotiating with that lipid matrix.

The 500-Dalton Rule

In 2000, Bos and Meinardi published what had long been a working rule of thumb: molecules above roughly 500 Daltons (Da) cross the stratum corneum poorly by passive diffusion. The rule has been refined and debated since, but as a first filter it remains one of the most useful heuristics in topical formulation science.

Several popular cosmetic ingredients sit above that line:

Sodium hyaluronate: commercial grades range from a few thousand Daltons to more than 1,000,000 Da. Its well-documented value is surface hydration and film formation.
Hydrolyzed collagen: typically 1,000 to 10,000 Da, working as a humectant and film former at the surface.
Cosmetic peptides: palmitoyl pentapeptide-4 is about 802 Da and acetyl hexapeptide-8 about 889 Da, both above the cutoff.

None of this makes those ingredients pointless. It means the vehicle they sit in matters, because the vehicle shapes how much of the ingredient is deposited and retained in the stratum corneum.

How Deposition Is Measured

The useful question to ask of a leave-on formula is not whether it contains ingredient X, but how much of ingredient X is found in the stratum corneum after normal use, and at what depth.

Cosmetic science answers that with in-vitro and surface methods: tape-strip deposition (removing stratum corneum layers one at a time and measuring the ingredient in each), Franz cell diffusion (measuring flux across a membrane under controlled conditions) and confocal Raman depth profiling (mapping an ingredient through the stratum corneum without removing anything). Together these produce depth and concentration profiles for a vehicle and an ingredient.

Published work on conventional creams and serums commonly reports that the amount of a larger ingredient drops steeply across the first few micrometres of the stratum corneum. Most of what is applied stays at or near the surface.

Why HLB-Based Emulsions Hit a Ceiling

The traditional answer has been to adjust the base cream or serum, using the Hydrophilic-Lipophilic Balance (HLB) system that William Griffin introduced in 1949 to choose surfactants for emulsions.

HLB does its intended job well: it keeps oil and water together long enough for a product to sit on a shelf and be used. It was never designed to control how an ingredient is presented to the stratum corneum.

The deeper limit is scale. Conventional cosmetic emulsion droplets range from about 0.5 to 5 micrometres, thousands of times larger than a 500 Da molecule. The ingredient may be small, but the droplet carrying it is not, and the droplet is what the skin surface meets first.

The Size Window in the Literature

From the 1990s onward, research on liposomes, solid lipid nanoparticles and nanostructured lipid carriers moved the focus from emulsion chemistry to particle engineering. That literature commonly describes a window of roughly 20 to 200 nanometres in which lipid-based vehicles show greater deposition in the stratum corneum and along follicular openings than conventional emulsions do in vitro.

Above about 200 nm, particles tend to stay on the surface. Below about 20 nm, they hold little ingredient. Within the window, composition matters as much as size: vehicles built from lipids that resemble the skin's own (phospholipids, ceramides, cholesterol, fatty acids) are reported to be more compatible with the lipid lamellae.

TDA Logic and NanoBase™

TDA Logic is Pensive Beauty's modern successor to 1940s HLB thinking. Instead of balancing surfactants for a single emulsion, it designs a formula around a tri-domain Architecture: nanocolloidal, nanoliposomal and nanomicellar domains designed to coexist, so water-soluble and oil-soluble ingredients can each be placed in a domain suited to them.

NanoBase™ is that Architecture, a cosmetic raw material used at 55% to 95% of a finished formula. Every variant is engineered to a ~185 nm design target, inside the literature's size window, and every batch is DLS-characterised for particle size and PDI. It is designed to an electrostatic (DLVO) stabilisation specification rather than an HLB surfactant system.

NanoBase™ makes no penetration or delivery claim of its own. It is the Architecture; the finished formula built on it is the delivery system, and the brand that completes that formula substantiates its claims with its own testing.

What to Ask of Any Formula's Delivery Claims

If you are judging whether a product's delivery claims are measured or just marketing, ask for four things:

Particle size. Hydrodynamic diameter, polydispersity index (PDI) and the instrument used. A measured product cites dynamic light scattering (DLS) data with both a size and a PDI. "Nano-sized" without a number is not a measurement.

Lipid composition. Which lipids, and whether they resemble the stratum corneum's own. A product claiming skin-identical lipids should be able to name them, for example ceramide NP, ceramide AP or ceramide EOP alongside cholesterol and fatty acids.

Stability data. Particle size and appearance over time at defined temperatures. A vehicle that drifts out of its size window on the shelf no longer behaves as designed.

Deposition data. Tape-strip, Franz cell or confocal Raman results on the finished formula. A claim of "deep delivery" with none of these behind it is an adjective, not a result.

The Takeaway

Relying on macro-emulsion physics to present above-500-Dalton ingredients to the skin solves for shelf life, not for where the ingredient ends up. The stratum corneum responds to molecular size, vehicle size and lipid compatibility, not to HLB values.

The question to ask of any leave-on product is not only what it contains, but how much of what it contains is found in the stratum corneum after use. The answer belongs to that formula's own data.